Sign inJoin waitlistJoin the waitlist

Wade Sexton

Chief Medical Officer · Duke University Hospital

Credentials: · · ·

History

H. Lee Moffitt Cancer Center and Research Institute
Present

Wake Forest University Baptist Medical Center
1995–2000
Emory University School of Medicine
1989–1993
Furman University
1985–1989

Research

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
The Lancet · 2016 · 501 citations
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2020 · 496 citations
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy
Journal of Clinical Oncology · 2004 · 335 citations

PS
Philippe Spiess
102 papers
SG
Scott Gilbert
56 papers
MP
Michael Poch
55 papers
JP
Julio Pow-Sang
50 papers
RL
Roger Li
29 papers · 3 as a fellow
LZ
Logan Zemp
28 papers · 6 as a fellow
Brandon Manley
24 papers
Jasreman Dhillon
21 papers
KZ
Kamran Zargar
21 papers
Charles Peyton
18 papers · 8 as a resident
Surena Matin
18 papers
JZ
Jingsong Zhang
17 papers

Clinical trials

Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2012–2016